Business
Press Release Nov 07 2022
Zydus Lifesciences Limited has informed the Exchange about press release dated 07-Nov-2022 titled Zydus receives EIR with Voluntary Action Indicated (VAI) from USFDA for its Moraiya manufacturing facility
About this update from Zydus Lifesciences Limited
[{"type":"text","content":" Zydus Lifesciences Limited has informed the Exchange about press release dated 07-Nov-2022 titled Zydus receives EIR with Voluntary Action Indicated (VAI) from USFDA for its Moraiya manufacturing facility View Attachment","length":358,"tagName":"div"}]